Humanized ALK Antibody-Drug Shows Cancer-Fighting Promise
In a groundbreaking advance toward precision oncology, researchers have unveiled a novel antibody-drug conjugate (ADC) specifically engineered to target anaplastic lymphoma kinase (ALK)-expressing cancers. This...